Organon & Co.

Ownership Transactions Reported by 33 Insiders

Symbol
OGN on NYSE
Industry
Pharmaceutical Preparations
Location
30 Hudson Street, Fl 33, Jersey City, NJ

Insiders trading volume in the past year

Organon & Co. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kevin Ali Chief Executive Officer, Director $2.49M +$299K +13.7% May 5, 2025
Cox Carrie Smith Executive Chair, Director $1.34M +$602K +81.6% Nov 12, 2025
Matthew M. Walsh Chief Financial Officer $1.27M +$101K +8.57% May 5, 2025
Rachel A. Stahler Chief Information Officer $1.12M Mar 31, 2025
Susanne Fiedler Chief Commercial Officer $1.08M Sep 3, 2024
Joseph T. Morrissey Jr. Interim CEO $1.04M Nov 13, 2025
Martha E. McGarry Director $756K Jun 7, 2024
Sandra Milligan Head of Research & Development $723K May 4, 2023
Vittorio Nisita Head of Global Business Svcs $636K Mar 31, 2025
Shalini Sharp Director $633K Jun 13, 2025
Cynthia M. Patton Director $630K Jun 13, 2025
Alan Ezekowitz Director $630K Jun 13, 2025
Grace Puma Whiteford Director $630K Jun 13, 2025
Philip Ozuah Director $630K Jun 13, 2025
Lazarus Rochelle B Director $630K Jun 13, 2025
Robert Essner Director $630K Jun 13, 2025
Helene D. Gayle Director $630K Jun 13, 2025
Deborah R. Leone Director $630K Jun 13, 2025
Ma. Fatima Francisco Director $566K Jun 9, 2023
Kathryn DiMarco Corporate Controller $562K Mar 31, 2025
Aaron Falcione Chief Human Resources Officer $552K +$48.2K +9.57% May 7, 2025
Kirke Weaver Gen. Counsel & Corp. Secy. $483K +$74.1K +18.1% May 6, 2025
Juan Camilo Arjona Ferreira Head of R&D & CMO $451K Nov 7, 2025
Daniel Karp Executive VP, Corp. Dev. $384K +$28.8K +8.11% May 6, 2025
Geralyn S. Ritter Head of Ext. Affairs and ESG $273K May 4, 2023
Deborah H. Telman EVP GC & Corporate Secretary $261K May 4, 2022
Ramona Sequeira Director $221K Jul 1, 2025
Juliana Drinane Interim Head of Mfg & Supply $132K Nov 13, 2025
Lynette Holzbaur SVP and Corporate Controller $84.4K Nov 7, 2025
Caroline Litchfield Director May 7, 2021
Jon Filderman Director May 7, 2021
Rita A. Karachun Director May 7, 2021
Merck & Co., Inc. 10%+ Owner Jun 2, 2021

Recent Insider Transactions by Companies or Individuals for Organon & Co.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.